Amyris logo
Amyris AMRS
report update icon

Quarterly report 2023-Q1
added 05-30-2026

Amyris Financial Ratios 2022-2008 | AMRS

Brief overview of Amyris's financial ratios

Current figures are compared with the company's own five-year history for 2018–2022.

The current valuation set is P/S 1.56x (median 3.9x), P/B 4.77x (median 23.05x). The combined multiple level is about 69.7% below the company's historical norm, suggesting more cautious expectations.

Returns on assets and capital are represented by ROE 108.1%, ROA -64.1%, ROCE 116.4%. The business is not generating positive returns on invested resources. Valuation should be read cautiously until earnings recover.

Price, earnings and growth produce a PEG of 0.61x. A value below one indicates moderate pricing relative to expected growth.

The cash conversion cycle decreased 19.6 days to -58.7 days, supporting working-capital efficiency.

Overall assessment

Amyris's multiples look low against history, but fundamental returns do not yet provide convincing support.

Annual Financial Ratios Amyris

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008

P/E

-0.8 -4.9 -8.5 -1.3 -1.2 -1.6 -1.4 -0.9 1389.0 -22.0 -12.2 -20.7 - - -

P/S

1.6 3.9 16.2 2.1 4.5 2.0 6.3 5.6 73.4 125.8 33.8 25.2 - - -

EPS

-1.6 -0.9 -1.9 -2.7 -3.7 -0.1 -2.7 -26.2 0.0 -3.1 -3.6 -4.0 -8.3 -13.6 -

EV (Enterprise Value)

1.65 B 1.52 B 3.17 B 734 M 581 M 549 M 421 M 444 M 3.47 B 5.5 B 2.64 B 3.77 B -93.2 M -19.2 M -17.9 M

EBITDA per Share

-1.74 -0.58 -0.56 -1.16 -2.18 -0.93 -4.64 -16 -1.08 -1.36 -3.3 -3.66 -1.74 - -

EV/EBITDA

-3.0 -9.0 -27.8 -6.3 -4.4 -12.3 -5.0 -3.3 -40.9 -53.4 -14.1 -22.4 1.2 0.3 -

PEG

-0.02 0.61 0.37 -0.01 -0.0 -0.01 -0.01 -0.0 0.58 -0.1 -0.09 -0.04 - - -

P/B

-0.9 4.8 -16.8 -1.3 -1.4 -1.2 -0.8 -1.2 -25.4 -38.1 37.6 23.1 - - -

P/CF

-0.8 -7.4 -16.0 -2.1 -2.6 -2.5 -1.7 -2.3 -37.5 -48.9 -16.5 -40.1 - - -

ROE %

108.15 -109.95 187.22 94.91 105.73 71.54 52.77 137.89 -1.84 173.82 -305.69 -111.06 -26.62 56.67 -

ROA %

-64.07 -28.39 -148.57 -150.82 -179.98 -110.79 -74.95 -205.39 1.06 -118.23 -84.48 -55.88 -22.90 - -

ROCE %

116.43 -72.08 69.80 2108.82 152.19 -266.67 -681.86 -439.76 -56.47 -73.77 -101.99 -78.55 -27.24 55.75 -

Current Ratio

0.6 1.4 0.6 0.4 0.4 0.4 0.4 0.4 0.6 0.6 1.4 2.0 7.2 - -

DSO

- - - 68.8 96.5 68.0 147.6 67.8 69.3 51.4 26.7 15.1 11.9 - -

DIO

131.9 138.7 146.8 89.7 75.1 34.0 40.0 106.3 159.5 103.9 28.5 21.3 - - -

DPO

190.6 142.0 191.8 187.0 210.7 90.3 98.6 77.6 38.4 62.1 72.7 61.9 - - -

Operating Cycle

131.9 138.7 146.8 158.5 171.6 102.1 187.6 174.1 228.7 155.3 55.2 36.4 11.8 - -

Cash Conversion Cycle

-58.7 -3.3 -45.0 -28.5 -39.1 11.8 89.0 96.6 190.4 93.2 -17.5 -25.5 11.8 - -

All numbers in USD currency

Quarterly Financial Ratios Amyris

2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.53 - -0.5 -0.34 -0.34 - -0.11 0.05 -1.08 - -0.37 -0.56 -0.56 - -0.56 -0.76 -0.82 - -1.13 0.02 -1.79 -0.06 -1.14 -0.44 -0.13 -2.67 -0.08 -0.06 -0.07 -0.23 -0.55 -0.59 -0.66 730 -0.46 -0.45 0.21 - -0.32 -0.51 -0.44 - -0.34 -0.81 -1.88 - -0.97 -0.95 -0.76

EBITDA per Share

-0.5 - -0.43 -0.43 -0.39 - -0.27 -0.16 0.36 - -0.18 -0.2 -0.19 - -0.34 -0.01 -0.63 - -0.45 -0.28 -0.36 - -0.43 -0.7 -0.08 - -0.01 -0.08 -0.11 - -0.15 -0.27 -0.27 - -0.13 -0.21 -0.3 - -0.2 -0.35 -0.36 - -0.15 -0.64 -1.6 - -0.8 -0.85 -0.67

ROE %

175.99 145.62 182.57 132.22 182.62 115.05 141.32 268.31 329.25 238.55 266.38 261.12 124.99 76.66 109.74 81.31 91.62 63.80 64.59 48.75 54.48 40.77 66.42 61.31 64.98 57.14 61.30 103.49 115.43 133.82 56.61 22.66 27.47 -15.32 -2367.51 -2574.64 -2654.62 -2640.00 -2666.20 -318.24 -202.63 -148.20 -169.65 -160.48 -130.19 -59.05 -21.45 -17.02 -20.58

ROA %

-76.97 -47.28 -53.36 -28.50 -103.75 -91.80 -103.05 -138.22 -194.18 -105.00 -151.49 -171.26 -193.01 -140.50 -196.19 -148.41 -194.83 -131.83 -133.05 -101.80 -112.20 -73.92 -110.24 -105.62 -109.33 -85.17 -93.19 -130.17 -146.63 -158.71 -86.31 -43.69 -26.91 7.07 -32.14 -37.15 -38.06 -44.96 -52.72 -56.21 -66.38 -52.97 -67.47 -72.84 -67.33 -37.98 -14.50 -13.13 -10.35

ROCE %

193.56 165.63 263.03 273.32 191.84 113.40 167.95 130.77 103.32 132.27 150.06 96.89 57.43 39.93 55.03 44.40 49.82 29.07 41.33 37.12 42.84 36.03 43.44 46.03 52.08 39.19 61.56 66.75 65.47 48.53 60.36 55.55 66.81 53.25 -2694.38 -2874.84 -2945.74 -2969.60 -2995.25 -296.63 -198.78 -145.42 -167.06 -158.52 -129.96 -59.19 -21.64 -17.10 -20.44

Current Ratio

0.5 - 0.7 0.8 0.9 1.4 0.9 0.8 0.5 0.6 0.7 0.8 0.5 0.4 0.4 0.4 0.3 0.4 0.4 0.3 0.3 0.4 0.4 0.4 0.3 0.4 0.4 0.4 0.4 0.4 0.5 0.4 0.5 0.6 0.6 0.7 0.7 0.6 1.0 1.1 1.3 1.4 1.4 1.4 1.7 2.0 3.1 4.4 2.0

DSO

- - - - - - - - - - - - - - - - - - 191.4 103.4 99.2 27.9 77.1 42.8 77.7 40.4 16.8 46.2 50.0 36.2 36.5 45.1 77.4 76.4 43.0 39.6 84.1 - 65.5 62.3 66.0 - 17.4 19.4 18.0 - 13.8 18.4 -

DIO

97.4 - 158.4 148.1 146.5 - 143.2 152.8 182.2 - 124.2 126.7 227.7 - 66.1 67.7 46.8 - 68.6 88.7 89.3 - 31.4 33.8 47.5 - - - - - - - - - - - - - - - - - - - - - - - -

DPO

178.7 - 164.1 156.0 156.4 - 146.5 139.1 171.6 - 93.9 141.7 387.6 - 124.5 181.2 142.9 - 162.8 268.8 271.0 - 90.7 82.2 113.5 - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

- - 158.4 148.1 146.5 - 143.2 152.8 182.2 - 151.5 169.3 273.3 - 122.7 167.6 96.5 - 302.0 294.6 257.4 27.9 120.8 114.8 176.0 57.4 46.5 124.6 88.6 37.1 42.5 46.6 73.6 68.4 48.5 85.2 124.0 - 100.8 65.0 67.1 - 18.4 18.2 16.7 - 17.4 19.8 -

Cash Conversion Cycle

- - -5.7 -8.0 -9.9 - -3.3 13.7 10.7 - 6.4 7.2 -83.8 - -103.7 -141.6 -104.7 - 16.3 -80.3 -106.2 27.9 38.4 30.8 64.4 57.4 46.5 124.6 88.6 37.1 42.5 46.6 73.6 68.4 48.5 85.2 124.0 - 100.8 65.0 67.1 - 18.4 18.2 16.7 - 17.4 19.8 -

All numbers in USD currency

Multiples are an important financial analysis tool for the company Amyris, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.

Advantages of Using Financial Ratios
  • Simplified Data Analysis
    Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition.
  • Comparability Between Companies
    Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations.
  • Identification of Trends and Issues
    Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks.
  • Decision Support
    Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions.
  • Accelerated Assessment of Investment Attractiveness
    Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.

Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.

Financial Ratios of other stocks in the Specialty chemicals industry

Issuer Price % 24h Market Cap Country
Gulf Resources Gulf Resources
GURE
- -2.8 % $ 44.6 M chinaChina
Ferro Corporation Ferro Corporation
FOE
- 0.27 % $ 1.84 B usaUSA
Axalta Coating Systems Ltd. Axalta Coating Systems Ltd.
AXTA
$ 35.97 0.5 % $ 7.77 B usaUSA
Cabot Corporation Cabot Corporation
CBT
$ 81.19 0.28 % $ 4.36 B usaUSA
Quaker Chemical Corporation Quaker Chemical Corporation
KWR
$ 160.33 0.39 % $ 2.8 B usaUSA
The Chemours Company The Chemours Company
CC
$ 15.48 3.81 % $ 2.33 B usaUSA
Chase Corporation Chase Corporation
CCF
- -0.01 % $ 1.2 B usaUSA
W. R. Grace & Co. W. R. Grace & Co.
GRA
- 0.03 % $ 4.64 B usaUSA
Loop Industries Loop Industries
LOOP
$ 0.52 0.87 % $ 24.9 M canadaCanada
Core Molding Technologies Core Molding Technologies
CMT
$ 24.04 0.06 % $ 206 M usaUSA
IKONICS Corporation IKONICS Corporation
IKNX
- -5.44 % $ 57.2 M usaUSA
Kraton Corporation Kraton Corporation
KRA
- -0.17 % $ 1.49 B usaUSA
Crown ElectroKinetics Corp. Crown ElectroKinetics Corp.
CRKN
- -16.67 % $ 15.5 M usaUSA
PQ Group Holdings Inc. PQ Group Holdings Inc.
PQG
- 0.58 % $ 2.14 B usaUSA
GCP Applied Technologies GCP Applied Technologies
GCP
- - $ 2.37 B usaUSA
Livent Corporation Livent Corporation
LTHM
- - $ 2.84 B usaUSA
The Sherwin-Williams Company The Sherwin-Williams Company
SHW
$ 332.26 0.3 % $ 82.3 B usaUSA
SenesTech SenesTech
SNES
$ 1.04 1.69 % $ 3.41 M usaUSA
Flexible Solutions International Flexible Solutions International
FSI
$ 5.72 0.17 % $ 72.4 M canadaCanada
Trecora Resources Trecora Resources
TREC
- 0.41 % $ 231 M usaUSA
Gevo Gevo
GEVO
$ 1.64 4.27 % $ 384 M usaUSA
Trinseo S.A. Trinseo S.A.
TSE
- - $ 8.12 M usaUSA
Kronos Worldwide Kronos Worldwide
KRO
$ 8.45 0.58 % $ 972 M usaUSA
Venator Materials PLC Venator Materials PLC
VNTR
- - $ 5.4 M britainBritain
Olin Corporation Olin Corporation
OLN
$ 16.97 3.09 % $ 1.94 B usaUSA
Oil-Dri Corporation of America Oil-Dri Corporation of America
ODC
$ 89.14 0.42 % $ 1.29 B usaUSA
Stepan Company Stepan Company
SCL
$ 62.38 0.35 % $ 1.43 B usaUSA
WD-40 Company WD-40 Company
WDFC
$ 210.46 1.28 % $ 2.85 B usaUSA
Avantor Avantor
AVTR
$ 15.19 3.69 % $ 10.3 B usaUSA
Element Solutions Inc Element Solutions Inc
ESI
$ 34.98 1.6 % $ 8.47 B usaUSA
Ingevity Corporation Ingevity Corporation
NGVT
$ 69.83 1.25 % $ 2.53 B usaUSA
Westlake Chemical Corporation Westlake Chemical Corporation
WLK
$ 74.6 1.21 % $ 9.57 B usaUSA
H.B. Fuller Company H.B. Fuller Company
FUL
$ 53.67 0.17 % $ 2.93 B usaUSA
Green Plains Green Plains
GPRE
$ 14.96 0.16 % $ 1.01 B usaUSA
Albemarle Corporation Albemarle Corporation
ALB
$ 132.16 1.64 % $ 15.6 B usaUSA
Ecolab Ecolab
ECL
$ 278.97 0.1 % $ 79 B usaUSA
International Flavors & Fragrances International Flavors & Fragrances
IFF
$ 86.46 0.06 % $ 22.1 B usaUSA
Koppers Holdings Koppers Holdings
KOP
$ 46.86 0.3 % $ 930 M usaUSA
Hudson Technologies Hudson Technologies
HDSN
$ 5.25 2.54 % $ 229 M usaUSA
Hawkins Hawkins
HWKN
$ 129.33 2.34 % $ 2.68 B usaUSA
Innospec Innospec
IOSP
$ 93.12 1.24 % $ 2.32 B usaUSA
NewMarket Corporation NewMarket Corporation
NEU
$ 900.15 0.12 % $ 8.45 B usaUSA
Northern Technologies International Corporation Northern Technologies International Corporation
NTIC
$ 8.03 1.64 % $ 76.1 M usaUSA
Linde PLC Linde PLC
LIN
$ 482.19 0.19 % $ 226 B britainBritain
LyondellBasell Industries N.V. LyondellBasell Industries N.V.
LYB
$ 64.76 2.34 % $ 20.9 B niderlandNiderland
Orion Engineered Carbons S.A. Orion Engineered Carbons S.A.
OEC
$ 5.97 5.11 % $ 336 M luxembourgLuxembourg
Balchem Corporation Balchem Corporation
BCPC
$ 171.74 1.25 % $ 5.54 B usaUSA
Avient Corporation Avient Corporation
AVNT
$ 42.91 2.28 % $ 3.93 B usaUSA
PPG Industries PPG Industries
PPG
$ 110.75 0.03 % $ 25.1 B usaUSA